Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | +2.85% | +3.41% | -31.54% |
05-07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.54% | 1.14B | |
+60.88% | 62.59B | |
-2.21% | 41.18B | |
+44.42% | 40.29B | |
-8.29% | 27.9B | |
+12.76% | 26.21B | |
-21.44% | 19.09B | |
+5.61% | 13.08B | |
+24.52% | 12.26B | |
+27.91% | 12.05B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- AbCellera Biologics : , Lilly Announce Expanded FDA Emergency Use Authorization for COVID-19 Antibody Therapy -- Shares Jump in Pre-Market